# Neuroprotection of Memantine and Rosuvastatin

> **NCT07504198** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 46 (estimated)

## Conditions studied

- Peripheral Nerve Disease

## Interventions

- **DRUG:** Starch Placebo
- **DRUG:** Memantine
- **DRUG:** Rosuvastatin 20 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT07504198
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-04
- **Final completion:** 2027-05
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07504198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07504198, "Neuroprotection of Memantine and Rosuvastatin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07504198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*